(2-Chloropyridin-3-yl)(3-(hydroxymethyl)piperidin-1-yl)methanone

Catalog No. :
ACCDNP516
CAS No. :
1156804-89-5
Molecular Formula :
C12H15ClN2O2
Molecular Weight :
254.72

IUPAC Name:(2-chloropyridin-3-yl)(3-(hydroxymethyl)piperidin-1-yl)methanone

(2-Chloropyridin-3-yl)(3-(hydroxymethyl)piperidin-1-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$93.00Login to see priceInquiryInquiry
250mg95%$157.00Login to see priceInquiryInquiry
1g95%$424.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Chloropyridin-3-yl)(3-(hydroxymethyl)piperidin-1-yl)methanone
IUPAC Name(2-chloropyridin-3-yl)(3-(hydroxymethyl)piperidin-1-yl)methanone
Molecular FormulaC12H15ClN2O2
Molecular Weight254.72
SMILESO=C(C1=CC=CN=C1Cl)N2CC(CO)CCC2
InChI KeyFWHXHERMJJAYTI-UHFFFAOYSA-N
Synonym(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone;Methanone, (2-chloro-3-pyridinyl)[3-(hydroxymethyl)-1-piperidinyl]-
CAS No.1156804-89-5
PubChem CID43422401

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCDNP516 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCDNP516 route product structure diagram
    ACCDNP5161156804-89-5
Inquiry

2. ACCDNP516 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCOGW615 route compound structure diagram
    ACCOGW61549609-84-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCDNP516 route product structure diagram
    ACCDNP5161156804-89-5
Inquiry

Comments (0)